Author:
Keck Martin E,Welt Tobias,Müller Marianne B,Uhr Manfred,Ohl Frauke,Wigger Alexandra,Toschi Nicola,Holsboer Florian,Landgraf Rainer
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference53 articles.
1. Altemus M, Cizza G, Gold PW (1992). Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro. Brain Res 593: 311–313.
2. Antoni FA (1993). Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14: 76–122.
3. Barberis C, Balestre MN, Jard S, Tribollet E, Arsenijevic Y, Dreifuss JJ et al (1995). Characterization of a novel, linear radioiodinated vasopressin antagonist: an excellent radioligand for vasopressin V1a receptors. Neuroendocrinology 62: 135–146.
4. Barberis C, Tribollet M (1996). Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurosci 10: 119–154.
5. Bhattacharya SK, Bhttacharya A, Chakrabarti A (1998). Anxiogenic activity of intraventricularly administered arginine–vasopressin in the rat. Biogenic Amines 14: 367–385.
Cited by
149 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献